ALKBH5 and ovarian carcinoma: In ovarian cancer, NGR-modified biomimetic nanovesicles (NGR-BNVs) achieved efficient delivery of ALKBH5 siRNA, markedly suppressing tumor proliferation and inducing apoptosis.